Lannett Company, Inc. to Present at UBS Warburg Global Generic and Specialty Pharmacueticals Conference

PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur Bedrosian, the company’s president and chief executive officer, will present at the 2007 UBS Global Generic and Specialty Pharmaceuticals Conference on May 8, 2007 at 9 a.m. EDT at the Grand Hyatt in New York City.

MORE ON THIS TOPIC